Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant PPX, Doxorubicin, and Metronomic Chemotherapy in Breast Cancer
NCT01227408Phase 2Withdrawn
- Sponsor
- University of Southern California
- Start
- Feb 2009
- Primary completion
- Feb 2010
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel poliglumex in breast cancer, sponsored by University of Southern California. Planned start Feb 2009; status: withdrawn.
02
Drugs
paclitaxel poliglumex
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01227408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01227408.